AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2017
Mar 31, 2017
35334_dirs_2017-03-31_1cf48190-6771-40cc-a3d4-acf211f99834.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2016-08-17
Reporting Person: Appelrouth Stewart (Director)